Skip to contentM
Mesa Laboratories Inc
M
MLABMesa Laboratories Inc Q1 2022 · 10-Q
Revenue$34.92M$34.92M+16.6% vs Q1 2021 Net Income$2.00M$2.00M+63.9% vs Q1 2021 EPS Diluted$0.38$0.38+72.7% vs Q1 2021 Gross Profit$22,211,000+11.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Mesa Laboratories Inc · CIK 724004 · Engraved from SEC EDGAR
Operating Cash Flow$9,589,000+363.7% Free Cash Flowderived$8,936,000+382.5% Margins · derivedGross margin63.6%−3.1 pt vs Q1 2021
Operating margin8.9%−1.7 pt vs Q1 2021
Net margin5.7%+1.6 pt vs Q1 2021
ended Jun 30, 2021 · filed Aug 5, 2021 · 36 d after period end